<DOC>
	<DOCNO>NCT00251888</DOCNO>
	<brief_summary>Search maximum tolerate irinotecan dose association cisplatin pelvic radiotherapy patient advance cervix cancer .</brief_summary>
	<brief_title>CAmpto-CISplatine Plus Radiotherapy Advanced Cervix Cancer : Search Tolerated Maximum Dose Campto</brief_title>
	<detailed_description>To determine maximum recommend tolerate dose irinotecan increase dos associate weekly cisplatin combinated pelvic radiotherapy patient advance cervix cancer , IIB-IVA FIGO stage .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologically proven primitive epidermoid andenocarcinoma Cervix FIGO stage IIB ( obviously parameter attack ) , III IVA No previous chemotherapy radiotherapy Patient radiochemotherapy envisage first intention treatmentof cervix carcinoma PS ECOG &lt; 2 Life expectancy &gt; 12 week Written consent give Other malignant cervix tumor histology Visceral remotly metastasis Other malignant tumor since 5 year , except spino basocellular treaten cure cancer Anormal labs value Peripheric neuropathy CTC &gt; 2 Auditory loss &gt; 2 Cardiopathy Inflammatory digestive pathology Evolutive infection Other experimental concommitant treatment Lacting pregnant woman</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>cervix cancer</keyword>
	<keyword>advanced cervix cancer</keyword>
	<keyword>radiochemotherapy</keyword>
	<keyword>pelvic radiotherapy</keyword>
	<keyword>campto</keyword>
	<keyword>cisplatin</keyword>
	<keyword>irinotecan</keyword>
	<keyword>cisplatyl</keyword>
	<keyword>maximum dose search</keyword>
</DOC>